|
Endocardial Mapping with the CoreMap EP Mapping System
RECRUITINGN/ASponsored by CoreMap Inc.
Actively Recruiting
PhaseN/A
SponsorCoreMap Inc.
Started2024-07-25
Est. completion2026-12-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06529978
Summary
This is a global, multi-site, prospective, feasibility study.
Eligibility
Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Subject has persistent or long-standing persistent AF, at the discretion of the investigator 2. Subject is 18 to 80 years of age 3. Patient scheduled for standard of care AF ablation 4. Subject is able to provide written informed consent 5. Subject is able and willing to complete all study procedures Exclusion Criteria: 1. Any of the following within three months of enrollment: 1. Myocardial infarction (MI) 2. Any surgical or percutaneous cardiac procedure including coronary intervention and cardiac ablation 3. Confirmed thrombus on imaging 2. Any of the following within six months of enrollment: a) Cardiac surgery including coronary artery bypass grafting, ventriculotomy, atriotomy b) Thromboembolic event (stroke) 3. Any of the following cardiac conditions: 1. New York Heart Association (NYHA) IV 2. Left ventricular ejection fraction (LVEF) \< 30% 3. Carotid stenting or endarterectomy 4. Atrial or ventricular septal closure or left atrial appendage closure 5. Implanted permanent pacemaker, biventricular pacemaker, or any type of implantable cardiac defibrillator 6. Presence of intramural thrombus, tumor (including atrial myxoma), or other abnormality that precludes vascular access, catheter introduction, or manipulation 7. Unstable angina 8. Prior mitral or tricuspid valve surgery, repair, prosthetic or mechanical valve 9. Moderate to severe mitral valve stenosis or other severe valvular disease 10. Any blood clotting or bleeding abnormalities 4. Contraindication to systemic anticoagulation 5. AF secondary to electrolyte imbalance, acute alcohol intoxication, or reversible or non-cardiac cause 6. Body mass index (BMI) \> 40 kg/m2 7. Severe pulmonary disease, pulmonary hypertension, or any chronic respiratory condition 8. Renal failure requiring dialysis or transplant 9. Acute illness, active systemic infection, or sepsis 10. Active drug or alcohol dependency 11. Any contra-indication that may extend procedure time, at the discretion of the operator 12. Any woman known to be pregnant or breastfeeding, or any woman of childbearing potential who is not on a reliable form of birth regulation method or abstinence 13. Subject considered part of vulnerable population 14. Life expectancy less than one year 15. Employee of the study site or Sponsor 16. Subjects who are currently enrolled in another study that would directly interfere with this study
Conditions2
Heart DiseasePersistent Atrial Fibrillation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorCoreMap Inc.
Started2024-07-25
Est. completion2026-12-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06529978